DNA RNA and Cells

25 Apr 2007 Ark Therapeutics Grp - Research Update
19 Apr 2007 Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
18 Apr 2007 Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
18 Apr 2007 Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
18 Apr 2007 Introgen's Intravenous Nanoparticle Gene Therapy Shows Activity in Stage IV Lung Cancer Patients
18 Apr 2007 ProNAi Announces Preclinical Success for PNT2258 Therapeutic – Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
17 Apr 2007 Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
17 Apr 2007 Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients
17 Apr 2007 Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
17 Apr 2007 Bioniche Presents Additional Data on the Anticancer Activity of MCC Against Peritoneal Carcinomatosis
14 Apr 2007 Ceregene Enrolling Patients For Phase 2 Clinical Trial Of Parkinson's Disease
12 Apr 2007 Oncolytics Biotech Inc. Proceeds to Initiate U.S. Phase II Sarcoma Clinical Trial
12 Apr 2007 Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
05 Apr 2007 Genta Appeals FDA Decision on Genasense in CLL
31 Mar 2007 LCT reports major step forward for islet transplantation in diabetes patient
27 Mar 2007 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
26 Mar 2007 Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease
24 Mar 2007 Genta Announces Expectation of a Negative Opinion from the CHMP on Genasense(R) Application for Advanced Melanoma
23 Mar 2007 Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
21 Mar 2007 La Jolla Pharmaceutical Company (LJPC) Provides Update on Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
20 Mar 2007 Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
15 Mar 2007 Transgene: First Patients Included in TG 1042 (Ad-IFNg) Phase II Clinical Trial in Cutaneous B-Cell Lymphoma
14 Mar 2007 Enzo Therapeutics Treats First Patient in Phase I/II Study of Antisense Gene Therapy for HIV-1 Infections
09 Mar 2007 TOPIGEN Initiates Expanded Phase II Trial of Inhaled TPI ASM8 in Patients With Asthma
09 Mar 2007 La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top